The addition of BRCA1 testing to obstetrical prenatal carrier screening is a cost-effective management strategy to identify at-risk women at a time when cancer screening and preventive strategies can be effective. Despite the burden of additional genetic counseling, prenatal care represents a unique opportunity to implement population-based genetic testing.
Keyphrases
- papillary thyroid
- pregnant women
- squamous cell
- healthcare
- breast cancer risk
- palliative care
- polycystic ovary syndrome
- squamous cell carcinoma
- lymph node metastasis
- childhood cancer
- quality improvement
- smoking cessation
- gene expression
- metabolic syndrome
- adipose tissue
- risk factors
- copy number
- skeletal muscle
- men who have sex with men
- affordable care act